Cryo-EM Structure of the Prostaglandin E Receptor EP4 Coupled to G Protein.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 07 10 2020
revised: 27 10 2020
accepted: 06 11 2020
pubmed: 3 12 2020
medline: 25 11 2021
entrez: 2 12 2020
Statut: ppublish

Résumé

Prostaglandin E receptor EP4, a class A G protein-coupled receptor (GPCR), is a common drug target in various disorders, such as acute decompensated heart failure and ulcerative colitis. Here, we report the cryoelectron microscopy (cryo-EM) structure of the EP4-heterotrimeric G protein (Gs) complex with the endogenous ligand at a global resolution of 3.3 Å. In this structure, compared with that in the inactive EP4 structure, the sixth transmembrane domain is shifted outward on the intracellular side, although the shift is smaller than that in other class A GPCRs bound to Gs. Instead, the C-terminal helix of Gs is inserted toward TM2 of EP4, and the conserved C-terminal hook structure formsthe extended state. These structural features are formed by the conserved residues in prostanoid receptors (Phe54

Identifiants

pubmed: 33264604
pii: S0969-2126(20)30419-6
doi: 10.1016/j.str.2020.11.007
pii:
doi:

Substances chimiques

Receptors, Prostaglandin E, EP4 Subtype 0
GTP-Binding Proteins EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

252-260.e6

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Shingo Nojima (S)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan.

Yoko Fujita (Y)

Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Kyoto 606-8507, Japan; Laboratory of Ultrastructural Virology, Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Kyoto 606-8507, Japan.

Kanako Terakado Kimura (KT)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan.

Norimichi Nomura (N)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan.

Ryoji Suno (R)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan; Department of Medical Chemistry, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.

Kazushi Morimoto (K)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan.

Masaki Yamamoto (M)

RIKEN Spring-8 Center, Life Science Research Infrastructure Group, Sayo-gun, Hyogo 679-5148, Japan.

Takeshi Noda (T)

Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Kyoto 606-8507, Japan; Laboratory of Ultrastructural Virology, Division of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Kyoto 606-8507, Japan.

So Iwata (S)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan.

Hideki Shigematsu (H)

RIKEN Spring-8 Center, Life Science Research Infrastructure Group, Sayo-gun, Hyogo 679-5148, Japan. Electronic address: hideki.shigematsu@riken.jp.

Takuya Kobayashi (T)

Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto 606-8501, Japan; Department of Medical Chemistry, Kansai Medical University, Hirakata, Osaka 573-1010, Japan. Electronic address: kobayatk@hirakata.kmu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH